Cargando…
Direct conversion of osteosarcoma to adipocytes by targeting TNIK
Osteosarcoma (OS) is an aggressive mesenchymal tumor for which no molecularly targeted therapies are available. We have previously identified TRAF2- and NCK-interacting protein kinase (TNIK) as an essential factor for the transactivation of Wnt signal target genes and shown that its inhibition leads...
Autores principales: | Hirozane, Toru, Masuda, Mari, Sugano, Teppei, Sekita, Tetsuya, Goto, Naoko, Aoyama, Toru, Sakagami, Takato, Uno, Yuko, Moriyama, Hideki, Sawa, Masaaki, Asano, Naofumi, Nakamura, Masaya, Matsumoto, Morio, Nakayama, Robert, Kondo, Tadashi, Kawai, Akira, Kobayashi, Eisuke, Yamada, Tesshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934882/ https://www.ncbi.nlm.nih.gov/pubmed/33400690 http://dx.doi.org/10.1172/jci.insight.137245 |
Ejemplares similares
-
Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma
por: Sekita, Tetsuya, et al.
Publicado: (2020) -
TNIK inhibition abrogates colorectal cancer stemness
por: Masuda, Mari, et al.
Publicado: (2016) -
Emergence of TNIK inhibitors in cancer therapeutics
por: Yamada, Tesshi, et al.
Publicado: (2017) -
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846
por: Sugano, Teppei, et al.
Publicado: (2020) -
Structural Insight into TNIK Inhibition
por: Kukimoto-Niino, Mutsuko, et al.
Publicado: (2022)